Viewing Study NCT00195520


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT00195520
Status: COMPLETED
Last Update Posted: 2008-08-05
First Post: 2005-09-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Evaluating TotelleĀ® in Menopausal Symptoms and Sexual Function
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Overview

Official Title: An Open Assessment of the Effect of Low-Dose TotelleĀ® 1 mg on Menopausal Symptoms, Sexual Function and Quality of Life
Status: COMPLETED
Status Verified Date: 2008-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the tolerability, bleeding patterns and acceptability of TotelleĀ® 1mg administered to a population of Brazilian women in a continuous combined regime for hormone replacement therapy.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: